There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agenus (AGEN – Research Report) and Zivo Bioscience (ZIVO – Research Report) with bullish sentiments.
Agenus (AGEN)
In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Agenus, with a price target of $6.00. The company’s shares closed last Wednesday at $0.59, close to its 52-week low of $0.53.
According to TipRanks.com, Mamtani has 0 stars on 0-5 stars ranking scale with an average return of
Agenus has an analyst consensus of Strong Buy, with a price target consensus of $6.67.
See Insiders’ Hot Stocks on TipRanks >>
Zivo Bioscience (ZIVO)
In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Zivo Bioscience. The company’s shares closed last Wednesday at $11.23.
According to TipRanks.com, Vendetti is a 1-star analyst with an average return of
Zivo Bioscience has an analyst consensus of Moderate Buy.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AGEN:
